[PRESSWIRE] Budapest - June 14, 2019 -- Kidney transplantation is the treatment of choice for most people with kidney failure, as it will improve their survival while increasing their quality of life compared to remaining on dialysis.
[PRESSWIRE] Budapest - June 14, 2019 -- In the CARMELINA trial nearly 10% of all patients with diabetes had nephrotic-range proteinuria at baseline. This was associated with a high incidence ofcardiovascular/kidney disease but this secondary disease burden could not be lowered by linagliptin.
[PRESSWIRE] Budapest, June 14, 2019 - As chronic kidney disease (CKD) progresses, the kidneys become less able to maintain a healthy balance of acids in the body, a condition known as metabolic acidosis.
[PRESSWIRE] Budapest - June 14, 2019 -- Epidemiological and clinical research and public policy in Europe are generally considered to be comprehensive and successful – and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) is playing a key role in the field of nephrology research.
[PRESSWIRE] Budapest - June 14, 2019 -- Acute kidney injury (AKI) is a common complication after cardiac surgery.The severity fluctuates from subclinical AKI, an increase in biochemical markers of kidney injury, to severe AKI requiring renal replacement therapy with dialysis.
[PRESSWIRE] Brussels, Belgium — June 13, 2019 -- Enhesa, the leading global content provider for environmental, health and safety (EHS) regulatory compliance, announced Peter Schramme as its new Chief Executive Officer (CEO).
[PRESSWIRE] Budapest - June 13, 2019 -- High cardiovascular morbidity and mortality remain a persisting problem in patients with CKD. Many efforts have been made in subjects with normal kidney function to prevent and to reduce the progression of cardiovascular diseases.
[PRESSWIRE] Budapest - June 13, 2019 -- Historically, the number of RCTs performed in the ESRD population has been very low compared to other medical subspecialties. Furthermore, several of the few large RCTs conducted in patients with ESRD have yielded inconclusive or negative results, dampening enthusiasm for future investment in similar trials.